使用韩国患者的喘血液eQTL识别喘相关基因
Dong Jun Kim1, Ji Eun Lim1, Hae-Un Jung2
1Department of Biochemistry and Molecular Biology, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.
BMC medical genomics
|October 24, 2023
概括
这项研究分析了韩国喘患者的基因表达,以发现新的喘相关基因. 研究人员确定了15个新基因,为喘治疗提供了潜在的治疗点.
科学领域:
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 全基因组关联研究 (GWAS) 已经确定了200多种与喘相关的遗传变异.
- 表达量的特征位点 (eQTL) 数据有助于从GWAS信号中精确定位因果基因.
- 现有的eQTL数据主要来自健康个体,这限制了其用于疾病特异性基因识别的实用性.
研究的目的:
- 在韩国喘患者中进行血液eQTL分析,以确定疾病特异性基因.
- 使用先进的分析方法,将喘GWAS结果与患者衍生的eQTL数据整合起来.
- 发现喘的新型治疗点.
主要方法:
- 在433名韩国喘患者的转录和基因型数据上进行了血液eQTL分析.
- 使用了局部化,基于摘要的门德尔随机化 (SMR) 和转录组广泛关联研究 (TWAS) 分析.
- 将特定疾病的eQTL数据与来自基因型-组织表达 (GTEx) 项目和日本研究的正常eQTL数据进行了比较.
主要成果:
- 从喘性eQTL分析中确定了340,274个cis-eQTL和2,875个eGenes.
- 发现喘eGenes与GTEx (64.1%) 和日本研究 (39.0%) 的eGenes之间存在显著的重叠.
- 通过与喘GWAS数据的综合分析,确定了15个与喘相关的基因,这些基因特定于韩国队列.
结论:
- 提供了新的韩国喘患者cis-eQTL数据.
- 通过整合eQTL和GWAS数据,确定了15个喘相关基因.
- 建议这些已识别的基因作为喘的潜在治疗点,有助于了解其病因.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
421
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
421
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K


